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Abstract
Mycobacteria have always proven difficult to identify due to their low growth rate and fastidious nature. Therefore
molecular biology and more recently nanotechnology, have been exploited from early on for the detection of these
pathogens. Here we present the first stage of development of an assay incorporating cadmium selenide quantum dots
(QDs) for the detection of mycobacterial surface antigens. The principle of the assay is the separation of bacterial cells using
magnetic beads coupled with genus-specific polyclonal antibodies and monoclonal antibodies for heparin-binding
hemagglutinin. These complexes are then tagged with anti-mouse biotinylated antibody and finally streptavidin-
conjugated QDs which leads to the detection of a fluorescent signal. For the evaluation of performance, the method under
study was applied on Mycobacterium bovis BCG and Mycobacterium tuberculosis (positive controls), as well as E. coli and
Salmonella spp. that constituted the negative controls. The direct observation of the latter category of samples did not
reveal fluorescence as opposed to the mycobacteria mentioned above. The minimum detection limit of the assay was
defined to 10
4 bacteria/ml, which could be further decreased by a 1 log when fluorescence was measured with a
spectrofluorometer. The method described here can be easily adjusted for any other protein target of either the pathogen
or the host, and once fully developed it will be directly applicable on clinical samples.
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Introduction
Most members of the genus Mycobacterium are harmless microbes
that live in diverse soil and aqueous environments; however, there
are a number of pathogenic species that affect humans and animals
causing mainly tuberculosis, leprosy, and paratuberculosis [1–4].
Despite their medical and environmental importance, myco-
bacteria have always proven difficult to identify. This is due to a
combination of factors, principal among them being their low
growth rate and fastidious nature. Therefore the application of
molecular biology methods was exploited from very early for the
detection of mycobacteria. However, incorporation of DNA
amplification techniques in routine diagnosis requires highly-
specialised personnel, dedicated equipment and space. The latter
is applied within the context of the vigorous precautions needed to
avoid the ‘‘carry over effect’’ (successive passage of amplicons from
one test sample to the other) that especially for the polymerase
chain reaction (PCR) can easily lead to false positive results even in
the presence of minute amounts of target DNA.
An alternative approach that might resolve the problems
mentioned above relies on the incorporation of nanotechnology
to the development of novel diagnostic tests. In recent years, many
nanosystems have been utilized for pathogen detection [5–7].
Semiconductor quantum dots (QDs) or nanocrystals have emerged
as a very promising class of fluorophores [8,9]. Unlike conven-
tional organic dyes, QDs can be excited by a wide spectrum of
wavelengths, they have great photostability, and their emission
spectra, which differ according to size and material composition,
are narrow, symmetrical, and tunable. With these characteristics,
QDs have minimal interference from natural autofluorescent
particles and can be used in the multiplex detection of different
molecular targets in various biological specimens [9].
Recently we developed two prototypical diagnostic assays
designed for use at point-of-care. These methods incorporate gold
nanoparticles [10] and a combination of magnetic beads (MBs) and
cadmium selenide QDs [11] for the detection of conserved genomic
regions of DNA belonging to Mycobacterium spp. without the need of
amplification. Here we present the first stage of the development of
thelatter ofthesemethods forthedetectionofmycobacterial surface
antigens using streptavidin-conjugated QD together with biotiny-
lated anti-Mycobacterium spp. polyclonal antibody.
Materials and Methods
Antibodies
The following antibodies were incorporated in the assay under
study: Two murine monoclonal antibodies against the Mycobacte-
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1G10, Icosagen Srl, Estonia). A biotinylated polyvalent antibody
produced in rabbit against Mycobacterium tuberculosis PPD, which
according to the manufacturer reacts with related mycobacterial
species (BP2027B, Acris Germany). A sheep anti-mouse biotiny-
lated antibody (R1256B, Acris, Germany).
Conjugation of MBs with anti-Mycobacterium antibodies
Stretavidin coated MBs (dynabeads M-280, Invitrogen, USA)
were functionalized with the biotinylated polyvalent antibody
mentioned above. For this purpose, 40 mg of antibody were added
to 200 ml (10 mg/ml) streptavidin coated MBs and incubated at
room temperature for 30 min. For the removal of unbound
antibody, conjugated MBs were washed 5 times with PBS with the
aid of a magnetic device (Dynal MPC-s, Invitrogen, CA, USA) and
dissolved in 200 ml of PBS containing 0.1% BSA.
Functionalization of QDs with streptavidin
Cadmium selenide (CdSe) QDs (15–20 nm in size) with a
maximum emission wavelength of 655 nm, shelled with ZnS and a
polymer coating presenting carboxylic groups were purchased by
Invitrogen (Q21321MP, Invitrogen, USA). QDs were coated with
streptavidin prior to use according to the manufacturer’s
instructions. Briefly, 50 ml of QDs were diluted in 400 mlo f
borate buffer 10 mM (pH 7.4), 96 ml of streptavidin solution
(10 mg/ml) (Invitrogen, CA, USA) and 11.4 ml of EDC (10 mg/
ml) (Sigma-Aldrich, MO, USA) and were incubated at room
temperature for 90 min. Streptavidin coated QDs were washed 5
times with 500 ml of borate buffer 50 mM (pH 8.3) on an Amicon
Ultra-4 Filter (Millipore, MA, USA) and dissolved into 50 mM
borate buffer (pH 8.3) to a final volume of 500 ml.
Bacterial strains
For the evaluation of performance, the method under study was
applied on Mycobacterium bovis BCG (Pasteur) and Mycobacterium
tuberculosis (n=3 isolates) (positive controls) that were grown on
Middlebrook 7H11 (BD, USA) with OADC (Oleic acid, Albumin,
Dextrose, Catalase) enrichment (BD, USA) and 0.4% pyruvate
(Sigma-Aldrich, Germany). Negative controls consisted of E. coli
(n=2 isolates) and Salmonella spp. (n=4 isolates) that were grown
on Brain Heart Infusion Agar (Oxoid, UK) for 24 h.
Limit of Detection
For the assessment of the limit of detection (LOD) of each
method we used duplicate solutions of Mycobacterium bovis BCG.
Two series of ten-fold dilutions ranging from 10
8 to 10 cells/ml
were prepared using standard bacteriological techniques. Briefly, a
few fresh colonies grown on solid media were suspended in sterile
screw cup glass tubes containing PBS and 6 glass beads. The
suspensions were mixed with a vortex for a few seconds in order to
break large clumps and were left to settle for 5 mins. The number
of bacteria in the suspension was determined with the aid of a
Petroff Hauser counting chamber. The LOD was defined as the
lowest concentration level that could be determined to be
statistically different from the negative controls (Analytical
detection limit guidance 1996).
Bacterial detection
The principle of the assay is based upon the separation of
bacterial cells using MBs coupled with genus-specific polyclonal as
well as the mouse monoclonal antibodies mentioned above. These
complexes are then tagged with anti-mouse biotinylated antibody
and finally streptavidin-conjugated QDs which lead to the
detection of a fluorescent signal (Figure 1). To this purpose, 1 ml
of each dilution of the bacteria that comprised positive and
negative controls or an equal volume of PBS BSA 0.1% (blank)
were coupled at first with 40 ml of genus specific polyclonal
antibody conjugated MBs, then with 1 mg (500 ng each) of HBHA
monoclonal antibody, then 10 ml (0.2 mg/ml) of an anti-mouse
biotinylated antibody (R1256B, Acris, Germany), and finally 40 ml
Figure 1. Bacterial cells (a) are separated from the matrix using MBs coupled with genus specific polyclonal antibodies (b) and a
magnetic device (c). These complexes are then tagged with anti-HBHA (d) and anti-mouse biotynylated antibody and streptavidin-conjugated QDs
(e) which lead to the detection of a fluorescent signal (f).
doi:10.1371/journal.pone.0020026.g001
QDs for Mycobacteria Detection
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dilutions were incubated at 37uC for 20 min with gentle agitation,
separated by the matrix with the aid of a magnetic device (Dynal
MPC-s, Invitrogen, CA, USA), washed once with PBS BSA 0.1%
and then re-suspended in 200 ml PBS 0.1% BSA. For the direct
visual observation of fluorescence, samples were transferred on a
UV transilluminator with UV emission at 312 nm (Vilber Loumat,
France). Fluorescence was also detected with a spectrofluorometer
(excitation 480 nm emission 655 nm, PMT 450V), (Infinite M200,
Tecan USA) and with an epifluorescence microscope with a 50 W
mercury lamp (AXIOSKOP 40, Carl Zeiss Light Microscopy
Germany) using the following filter set 460SPUV/475DCXRU/
D655/40 nm (Chroma Technology, USA).
Results
Conjugation of MBs with anti-Mycobacterium antibodies
Assessment of the immobilization of antibodies on the surface of
MBs was performed by spectrophotometric measurement at
280 nm of the antibody solution before and after conjugation
with nanoparticles (data not shown). Confirmation on the same
issue was provided by the microscopic observation of Ziehl-
Neelsen stained preparations of MBs with and without the
antibodies that were used for the immunocapture of BCG cells.
As shown in Figure 2 the observation of bacterial cells closely
associated with MBs was possible only in the case of those coupled
with antibodies while in the absence of antibody no bacteria were
observed.
Bacterial detection/Limit of Detection
The direct visual observation of blanks and negative controls did
not reveal any fluorescent signal (Figure 3) as opposed to the
mycobacteria pathogens reported above that reacted positively at
or above the LOD concentration.
The LOD of the methodology described here was defined to 10
4
bacteria/ml of sample when results were assessed by visual
observation of the test tubes (Figure 3). The detection limit of the
method could be further decreased to 10
3 bacterial cells/ml when
Figure 2. Comparison of the ability of free (A) and antibody conjugated (B) magnetic beads to capture BCG bacilli. The detection of
acid fast bacteria was possible only in the second case. (Zhiel Neelsen stain 1000X).
doi:10.1371/journal.pone.0020026.g002
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orometer (Figure 4).
In order to perform a validation of the read-out, microscopic
slide smears were prepared from the samples (negative controls
and serial dilutions of the positive controls) and they were
examined by fluorescence microscopy. This revealed the presence
of magnetic beads surrounded by a fluorescent halo with
dimensions comparable to those of mycobacteria only for the
positive and for none of the negative controls (Figure 5).
Discussion
Previously we presented a method incorporating CdSe QDs
for the detection of mycobacterial DNA that is not prone to false
results associated with PCR-inhibitors or the carry over effect
since it does not involve amplification of DNA [11]. The same
method that proved its efficiency on clinical samples is adapted
here for the detection of mycobacterial surface antigens. In this
case the methodology is simplified in that it does not require
sample processing for DNA isolation, which facilitates its
incorporation at point-of-care. The use of QDs in the pro-
posed approach bypasses the disadvantages of fluorescent dyes
often incorporated into immuno-detection tests such as rapid
photobleaching, narrow excitation spectrum and low signal
intensity.
The evidence provided here indicate that streptavidin-conju-
gated CdSe QDs can specifically bind to the mycobacterial
pathogens incorporated in this study after their separation using
antibody coupled MBs. The procedure is very easy to perform and
does not require any dedicated equipment. Combined with a
simple spectrophotometer the suggested approach allows direct
detection of 1000 bacterial cells/ml of sample, which can be
further improved by the use of alternative or multiple protein
targets and brighter QDs.
Figure 4. Relative fluorescence values of BCG and E. coli serial dilutions.
doi:10.1371/journal.pone.0020026.g004
Figure 3. Results recorded by the proposed method for E. coli and M. bovis BCG serial dilutions ranging from 10
8to 10
1 cfu/ml
(numbers 1–8) and negative controls. Fluorescence is evident in BCG samples with concentration up to 10
4 cfu/ml.
doi:10.1371/journal.pone.0020026.g003
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HBHA antigen. This is a 28-kDa, methylated surface-associated
protein that mediates the interaction of the tubercle bacilli with the
host. HBHA acts as an adhesin for non-phagocytic cells such as
epithelial, playing an important role in the systemic extra-
pulmonary dissemination of Mycobacterium tuberculosis [12,13].
Expectedly HBHA has been under investigation towards the
development of vaccines and tests as a significant immuno-reactive
protein and a clinical indicator of tuberculosis [14,15].
Owing to the evident significance of HBHA it was considered a
good candidate for the development of the method under study
that was designed to target the protein itself rather than the
immune response to it. The latter which would have simplified the
procedure significantly, was not selected for this stage of
development, since our aim was to demonstrate that the specific
approach can support detection of mycobacteria in a reliable
manner using at the same time clinically significant indicators. For
reasons of applicability the method described here incorporates a
combination of mycobacterial polyclonal and monoclonal anti-
body that increases specificity and at the same time facilitates its
adjustment for any other protein target, either of the pathogen or
the host. Evidently the assay can be easily extended to the
detection of any other bacterium as the adaptation of the method
would require only the incorporation of specific antibodies for the
pathogen in question.
Once fully developed, the method described here will be directly
applicable on clinical samples in the context of the one previously
reported [11]. Combined with the latter, the proposed application
will allow detection of both DNA and protein targets in a simple
manner using the same methodology with different types of
nanoprobes, without dedicated instrumentation apart from a
magnetic device and a UV lamp.
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